| Autor: |
Laffey KG; Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, MO 65212, USA.; Institute for Data Science and Informatics, University of Missouri, Columbia, MO 65212, USA., Nelson AD; Department of Surgery, School of Medicine, University of Missouri, Columbia, MO 65212, USA., Laffey MJ; Institute for Data Science and Informatics, University of Missouri, Columbia, MO 65212, USA., Nguyen Q; Institute for Data Science and Informatics, University of Missouri, Columbia, MO 65212, USA., Sheets LR; Department of Health Management and Informatics, School of Medicine, University of Missouri, Columbia, MO 65212, USA., Schrum AG; Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, MO 65212, USA.; Department of Surgery, School of Medicine, University of Missouri, Columbia, MO 65212, USA.; Department of Biomedical, Biological, and Chemical Engineering, College of Engineering, University of Missouri, Columbia, MO 65212, USA. |
| Abstrakt: |
American Indian/Alaska Native (AI/AN) persons in the US experience a disparity in chronic respiratory diseases compared to white persons. Using Behavioral Risk Factor Surveillance System (BRFSS) data, we previously showed that the AI/AN race/ethnicity variable was not associated with asthma and/or chronic obstructive pulmonary disease (COPD) in a BRFSS-defined subset of 11 states historically recognized as having a relatively high proportion of AI/AN residents. Here, we investigate the contributions of the AI/AN variable and other sociodemographic determinants to disease disparity in the remaining 39 US states and territories. Using BRFSS surveys from 2011 to 2019, we demonstrate that irrespective of race, the yearly adjusted prevalence for asthma and/or COPD was higher in the 39-state region than in the 11-state region. Logistic regression analysis revealed that the AI/AN race/ethnicity variable was positively associated with disease in the 39-state region after adjusting for sociodemographic covariates, unlike in the 11-state region. This shows that the distribution of disease prevalence and disparity for asthma and/or COPD is non-uniform in the US. Although AI/AN populations experience this disease disparity throughout the US, the AI/AN variable was only observed to contribute to this disparity in the 39-state region. It may be important to consider the geographical distribution of respiratory health determinants and factors uniquely impactful for AI/AN disease disparity when formulating disparity elimination policies. |
